Real-world efficacy, safety, and associated biomarkers of cadonilimab in cervical cancer: a prospective observational study.

Furthermore, we observed a trend toward a higher incidence of AEs in patients with a lower baseline CD3 + CD4 + /CD3 + CD8 + ratio during cadonilimab treatment, although this trend did not reach statistical significance (p > 0.05).

also in 111,027 other papers

Additionally, ethnic minority status and low baseline CD3 + levels showed a trend toward higher ORR in univariate logistic regression analysis, though without statistical significance, warranting further validation through long-term follow-up.

also in 53,322 other papers